Our Gainesville location offers patients an in-house Infusion center.
WHAT IS INFUSION THERAPY?
Infusion therapy is a type of medical treatment in which medication is delivered through a needle or catheter directly into the body via blood vessel, the spinal cord, or a muscle. It is prescribed when a patient's condition has become severe enough to no longer be effectively treated through oral medications.
INFUSION THERAPY AT GASTROENTEROLOGY ASSOCIATES OF GAINESVILLE, P.C.
Our Gainesville location offers an infusion center, here you can enjoy the convenience of not having to travel to a secondary facility to receive your treatments. Our Infusion Center has been designed with comfort in mind, offering our patients a safe space to relax while receiving their treatments. Additional benefits our patients enjoy while having their treatments include:
-Nurse dedicated solely to infusion
-Familiar surroundings at an easily accessible facility
Medications administered at this location are for patient's suffering from Crohn's Disease and Colitis. Appointments are offered Tuesday through Thursday, and require a referral from a physician in order to be scheduled. Once the referral has been received our infusion nurse will work with our patients to schedule visits, obtain prior-authorizations( if required by the insurance), and assist with any additional questions.
*Please be aware Gastroenterology Associates of Gainesville, P.C. has partnered with Altus Infusion on this center. At times it will be necessary to direct our patients to Altus Infusion in order to provide the most accurate information regarding infusion services.*
REQUEST AN APPOINTMENT
Interested in scheduling an Infusion consultation? Submit a request online today, and our appointment scheduling team will contact you to confirm a date and time.
If you have additional questions, please contact us at 770-536-8109 our associates will be happy to assist you.
Gastroenterology Associates Pathology Department
Our compliance with the National Patient Safety Goals
was validated by the Joint Commission in January 2019